J3 Bioscience Competitors

Melior Discovery Inc (Exton, PA, USA) has pioneered a unique “high throughput” in vivo pharmacology platform (theraTRACE®) able to systematically identify novel indications for pre-clinical and development stage drugs. theraTRACE® is widely used by both multinational pharmaceutical and start-up biopharmaceutical companies alike to fully explore the therapeutic potential of their drug candidates. Melior has also leveraged this expertise to build a high quality, onshore, preclinical services capability offering in vivo efficacy models in a broad range of therapeutic areas, pharmacokinetic evaluations, specialized animal models and bioanalytical services to drug developers worldwide.

PRESCOS LLC — Preclinical Research and Scientific Consulting Services is a preclinical CRO that provides in vivo contract research services (disease models and PK studies), as well as expert consulting services, supporting the preclinical drug research and development of emerging and established pharmaceutical and biotechnology companies.